News & Analysis on Clinical Trial Services & Contract Research And Development
Sen. Tom Carper (D-Del.) introduced a bill last week that aims to further incentivize research in the US and allows CROs (contract research organizations) to capture a share of the R&D tax credit when research is outsourced.
Quintiles CEO Tom Pike told investors last week that the company is seeing “very strong demand from the larger pharmaceutical firms because their pipelines are full right now,” and at the same time, small biotech, with their plethora of funding, are...
The Health Products Regulatory Authority (HPRA) of Ireland has published a list of 12 active substances contained in medicines that could potentially be switched from prescription-only to over the counter sale.
This summer, the National Institutes of Health (NIH) announced another funding opportunity for experimental drugs proven safe but sitting on the shelves of pharmaceutical companies. The NIH-sponsored effort is based on a crowdsourcing strategy to...
AstraZeneca has bolstered its respiratory portfolio and added new bronchodilator technologies through the $875m (€650m) acquisition of Almirall.
China has tightened its GMP requirements and compliant API suppliers will benefit from a reduction in competition, according to ScinoPharm.